Hannah Victoria Giles

5PUBLICATIONS
7CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsClinical chemistry (incl. diagnostics)Predictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 21, 2026
Bispecific Antibodies: Strategies Available to Optimize Their Safe Delivery in Patients with Multiple Myeloma.

Hannah Victoria Giles, Bhuvan Kishore

|Mar 27, 2024
Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies.

Hannah V Giles, Kamaraj Karunanithi

|Mar 19, 2024
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.

H V Giles, M T Drayson, B Kishore

|May 06, 2022
The potential role of mass spectrometry for the identification and monitoring of patients with plasma cell disorders: Where are we now and which questions remain unanswered?

Hannah V Giles, Ashutosh Wechalekar, Guy Pratt

|Dec 20, 2020
Janus kinase 2 (JAK2) inhibitors in the treatment of multiple myeloma: modulating the myeloma immune microenvironment.

Hannah Giles, Guy Pratt

Pageof 1

Frequent Collaborators

2 joint publications

Guy Pratt

1 joint publications

M T Drayson

1 joint publications

C Pawlyn

1 joint publications

M Kaiser